Qishen Yiqi Dripping Pills placebo 3 bags

DRUG2 trials

Sponsors

Tasly Pharmaceutical Group Co., Ltd

Conditions

Chronic Heart Failure With Reduced Ejection FractionDiabetic Kidney Disease

Phase 2

Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure

CompletedNCT04983043

Tasly Pharmaceutical Group Co., LtdChronic Heart Failure With Reduced Ejection Fraction

Start: 2021-06-10End: 2024-11-27Updated: 2025-01-10

Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)

RecruitingNCT06006689

Tasly Pharmaceutical Group Co., LtdDiabetic Kidney Disease

Start: 2023-09-04End: 2025-09-01Target: 228Updated: 2024-03-13

Related Papers

Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Coronary Heart Disease Complicating Chronic Heart Failure (Syndrome of Qi Deficiency with Blood Stasis): Study Protocol for a Randomized, Placebo-Controlled, Double-Blind and Multi-Centre Phase II Clinical Trial

International Journal of General Medicine2023-12-016 citations